SUMMARY This is the first report of human gastrointestinal arachidonate and prostanoids measured quantitatively by gas chromatography-mass spectrometry (GC-MS) in extracts of human cancers and macroscopically normal tissues from the stomach and colon. There were Rg/g amounts of arachidonate, and the particularly high yield from the tumours may explain why they usually produce more prostaglandins than the normal tissues in which they arise. There was only a small conversion of the arachidonate into prostanoids. 6-Keto-PGFI, was The methods for gas chromatography-mass spectrometry (GC-MS) were as reported previously.' In brief, the dried extract obtained as described above was dissolved in dichloromethane. An aliquot was taken for GC-MS and further purified by LH20 column chromatography; non-polar impurities were eluted with dichloromethane, and the eicosanoids were eluted with methanol which was then evaporated. Deuterated standards were added, and each dried methanol extract was dissolved in doubledistilled water acidified to pH 3 with hydrochloric acid. Each solution was percolated through an Amberlite column which was then washed with distilled water, and the eicosanoids were eluted with 315 (Table 2) . Although the overall statistical comparison for 6-keto-PGF10, including data from unpaired tissues was p<O-05, only three of 
had not recently taken any drugs known to affect prostaglandin synthesis. Tumour, and/or macroscopically normal tissue taken at least 5 cm from the site of any abnormality, were cleared of mesentery and fat, and the mucosal layers separated from the muscle. The fresh muscle, mucosa and/or tumour were cut into small pieces (approximately 2 mm3) and washed in Krebs solution. Weighed portions were homogenised (0. 1 g tissue/ml; 30 s; Silverson homogeniser) at room temperature in Krebs solution, and the individual homogenates were extracted for prostaglandins using chloroform/formic acid. " ' The methods for gas chromatography-mass spectrometry (GC-MS) were as reported previously.' In brief, the dried extract obtained as described above was dissolved in dichloromethane. An aliquot was taken for GC-MS and further purified by LH20 column chromatography; non-polar impurities were eluted with dichloromethane, and the eicosanoids were eluted with methanol which was then evaporated. Deuterated standards were added, and each dried methanol extract was dissolved in doubledistilled water acidified to pH 3 with hydrochloric acid. Each solution was percolated through an Amberlite column which was then washed with distilled water, and the eicosanoids were eluted with 315 methanol. The Using radioimmunoassay of human gastric mucosal incubates, Jeremy et al' also found that the prostanoid yield was 6-keto-PGF1,>PGE2>PGF2a, and Whittle and Salmon' found a slightly greater production of 6-keto-PGFt,, than of PGE2. In contrast, Peskar et al,7 obtained more PGE2 than 6-keto-PGFI,, with endogenous substrate, and Ahlquist et al,"2 found that the prostanoid formation from [14C1-arachidonic acid by human fundic mucosa was PGE2 >PGD2= PGF20>6-keto-PGFt0a>TXB2.
With regard to the colon, Boughton-Smith et al'1 homogenised five specimens of human colonic mucosa and then incubated them with exogenous ['4Cl-arachidonic acid. Their yields were PGE2> PGF2(1> PGD2 > TXB > 6-keto-PGF),(, in contrast with our finding of most 6-keto-PGFI,1.
The reasons for different prostaglandin yields obtained by the various groups is likely to be partly methodological, but there are other factors such as losses during extraction and preparation for assay, and variables such as each patient's age, sex, disease, and medication.
Exact measurements of prostanoid formation may well be of value in studying aspects of physiology and pathology, provided that the samples are obtained, extracted and assayed under standardised conditions. There is little merit, however, in making comparisons when this is not the case, and we must also bear in mind that different cell types in the tissues, including blood elements, contribute to the yield. Nevertheless, it is important to know what types of prostanoids can be produced by tissues, and whether their amounts might be sufficient to affect the biological activity. Our results with gas chromatography -mass spectrometry, a method without the specificity problems of other assays, suggests that this may be so for various prostanoids.
With regard to gastrointestinal malignancy, previous work has shown that human colonic cancer cells released more PGE-like substance than did normal cells.'4 Gastrointestinal tumours often, but not always, produced more PG-LM than normal mucosa, as judged by bioassay on rat gastric fundus,' and many other cancers produce raised amounts of prostaglandins (see ref '5) . In 
